|
|
|
|
| LEADER |
03534nma a2201093 u 4500 |
| 001 |
EB002043972 |
| 003 |
EBX01000000000000001187638 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
220822 ||| eng |
| 020 |
|
|
|a 9783036516851
|
| 020 |
|
|
|a 9783036516868
|
| 020 |
|
|
|a books978-3-0365-1685-1
|
| 100 |
1 |
|
|a Navarro, Alfons
|
| 245 |
0 |
0 |
|a Role of miRNAs in Cancer
|h Elektronische Ressource
|b Analysis of Their Targetome
|
| 260 |
|
|
|a Basel
|b MDPI - Multidisciplinary Digital Publishing Institute
|c 2022
|
| 300 |
|
|
|a 1 electronic resource (302 p.)
|
| 653 |
|
|
|a radiotherapy
|
| 653 |
|
|
|a HCV
|
| 653 |
|
|
|a radioactive iodine
|
| 653 |
|
|
|a immune regulation
|
| 653 |
|
|
|a angiogenesis
|
| 653 |
|
|
|a cell growth
|
| 653 |
|
|
|a transcription factor
|
| 653 |
|
|
|a EP4
|
| 653 |
|
|
|a n/a
|
| 653 |
|
|
|a MCPyV
|
| 653 |
|
|
|a tumor microenvironment
|
| 653 |
|
|
|a post-transcriptional regulation
|
| 653 |
|
|
|a liquid biopsies
|
| 653 |
|
|
|a pancreatic cancer
|
| 653 |
|
|
|a exosomes
|
| 653 |
|
|
|a Oncology / bicssc
|
| 653 |
|
|
|a HBV
|
| 653 |
|
|
|a EBV
|
| 653 |
|
|
|a radioresistance
|
| 653 |
|
|
|a drug resistance
|
| 653 |
|
|
|a thyroid carcinoma
|
| 653 |
|
|
|a miR-378a-3p
|
| 653 |
|
|
|a long non-coding RNAs (lncRNAs)
|
| 653 |
|
|
|a tumor
|
| 653 |
|
|
|a Burkitt lymphoma
|
| 653 |
|
|
|a micro RNA
|
| 653 |
|
|
|a microRNAs
|
| 653 |
|
|
|a glioblastoma
|
| 653 |
|
|
|a PI3K/Akt
|
| 653 |
|
|
|a SNAIL (SNAI1) transcription factor
|
| 653 |
|
|
|a liquid biopsy
|
| 653 |
|
|
|a epithelial to mesenchymal transition (EMT)
|
| 653 |
|
|
|a prognostic biomarker
|
| 653 |
|
|
|a viral miRNAs
|
| 653 |
|
|
|a translational medicine
|
| 653 |
|
|
|a genetic marker
|
| 653 |
|
|
|a oncomiRNA
|
| 653 |
|
|
|a microRNA-361
|
| 653 |
|
|
|a breast cancer
|
| 653 |
|
|
|a lymphangiogenesis
|
| 653 |
|
|
|a HHV-8
|
| 653 |
|
|
|a personalized medicine
|
| 653 |
|
|
|a progression
|
| 653 |
|
|
|a ccRCC
|
| 653 |
|
|
|a prognosis
|
| 653 |
|
|
|a cancer
|
| 653 |
|
|
|a circular RNAs
|
| 653 |
|
|
|a survival
|
| 653 |
|
|
|a interplay
|
| 653 |
|
|
|a biomarker
|
| 653 |
|
|
|a non-coding RNA
|
| 653 |
|
|
|a EMT
|
| 653 |
|
|
|a cancer treatment
|
| 653 |
|
|
|a metastasis
|
| 653 |
|
|
|a cancer diagnosis
|
| 653 |
|
|
|a temozolomide
|
| 653 |
|
|
|a MGMT
|
| 653 |
|
|
|a miR526b
|
| 653 |
|
|
|a chemotherapy
|
| 653 |
|
|
|a miRNA
|
| 653 |
|
|
|a target
|
| 653 |
|
|
|a HPV
|
| 653 |
|
|
|a miR655
|
| 653 |
|
|
|a Medicine and Nursing / bicssc
|
| 653 |
|
|
|a Bladder cancer
|
| 653 |
|
|
|a adrenocortical carcinoma
|
| 653 |
|
|
|a microRNA
|
| 700 |
1 |
|
|a Navarro, Alfons
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b DOAB
|a Directory of Open Access Books
|
| 500 |
|
|
|a Creative Commons (cc), https://creativecommons.org/licenses/by/4.0/
|
| 024 |
8 |
|
|a 10.3390/books978-3-0365-1685-1
|
| 856 |
4 |
0 |
|u https://www.mdpi.com/books/pdfview/book/5202
|7 0
|x Verlag
|3 Volltext
|
| 856 |
4 |
2 |
|u https://directory.doabooks.org/handle/20.500.12854/81171
|z DOAB: description of the publication
|
| 082 |
0 |
|
|a 363
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a MicroRNAs are the best representatives of the non-coding part of the genome and their functions are mostly linked to their target genes. During the process of carcinogenesis, both dysregulation of microRNAs and their target genes can explain the development of the disease. However, most of the target genes of microRNAs have not yet been elucidated. In this book, we add new information related to the functions of microRNAs in various tumors and their associated targetome.
|